Search Results

You are looking at 1 - 10 of 10 items for :

  • "peripheral arterial disease" x
  • Refine by Access: Open Access content only x
Clear All
Open access

Jing Hong, Wen-Yue Liu, Xiang Hu, Fei-Fei Jiang, Ze-Ru Xu, Fang Li, Fei-Xia Shen, and Hong Zhu

, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OHA, oral hypoglycemic agent; PAD, peripheral arterial disease; QTc, heart rate-corrected QT interval; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride

Open access

Xiaomei Zhang, Zhangrong Xu, Xingwu Ran, and Linong Ji

:// ) 2 Criqui MH Langer RD Fronek A Feigelson HS Klauber MR McCann TJ Browner D . Mortality over a period of 10 years in patients with peripheral arterial disease . New England Journal of Medicine 1992 326 381 – 386

Open access

Po-Chung Cheng and Chia-Hung Kao

kidney dysfunction ( 2 ). Importantly, diabetes is also linked to macrovascular diseases such as coronary heart disease (CHD) and peripheral arterial disease ( 3 ). Indeed, cardiovascular disease is a prevalent risk factor of mortality in T2DM ( 4 ), and

Open access

Yusaku Mori, Hiroyuki Shimizu, Hideki Kushima, Tomomi Saito, Munenori Hiromura, Michishige Terasaki, Masakazu Koshibu, Hirokazu Ohtaki, and Tsutomu Hirano

Supplementary Fig. 2). There are several limitations of the current study. First, we evaluated the vasoprotective effects of nesfatin-1 in mouse models of wire injury. Despite widespread application in studies of peripheral arterial disease ( 40 ), the present

Open access

Henrik H Thomsen, Holger J Møller, Christian Trolle, Kristian A Groth, Anne Skakkebæk, Anders Bojesen, Christian Høst, and Claus H Gravholt

of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease . Atherosclerosis 2011 219 892 – 899 . ( doi:10.1016/j.atherosclerosis.2011.09.016 ). 39 Ishikawa T Yamaguchi K Kondo

Open access

Laura P B Elbers, Marije Wijnberge, Joost C M Meijers, Dennis C W Poland, Dees P M Brandjes, Eric Fliers, and Victor E A Gerdes

.1177/1076029613509477 ) 10.1177/1076029613509477 14 Stricker H Tosi Bianda F Guidicelli-Nicolosi S Limoni C Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised

Open access

Xiaoli Liu, Lanxiang Liu, Rui Wang, Xiaojiao Jia, Binbin Liu, Ning Ma, and Qiang Lu

atherosclerosis. It is an accurate, reliable, and noninvasive detection index for the early diagnosis of peripheral arterial diseases ( 6 , 7 ). Fibroblast growth factor 21 (FGF21) is a metabolic regulator that has multiple functions, such as reducing blood

Open access

Johanna Christina Penell, Mark M Kushnir, Lars Lind, Jonatan Bergquist, Jonas Bergquist, P Monica Lind, and Tord Naessen

Mellstrom D Jutberger H Fagerberg B Lernfelt B Orwoll E Karlsson MK Ljunggren O Ohlsson C Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden

Open access

A H Ludwig-Slomczynska, S Borys, M T Seweryn, J Hohendorff, P Kapusta, B Kiec-Wilk, E Pitera, P P Wolkow, and M T Malecki

Introduction Diabetic foot syndrome (DFS) is characterized as an infection, ulceration, or destruction of deep tissues of the foot associated with neuropathy and/or peripheral arterial disease ( 1 ). Diabetic foot ulcer (DFU) is a frequently

Open access

Jairo Arturo Pinzón-Cortés, Angelina Perna-Chaux, Nicolás Steven Rojas-Villamizar, Angélica Díaz-Basabe, Diana Carolina Polanía-Villanueva, María Fernanda Jácome, Carlos Olimpo Mendivil, Helena Groot, and Valeriano López-Segura

arterial disease) and microvascular diseases (neuropathy, retinopathy and neuropathy), plus many other alterations that predispose to cognitive decline and bone fragility. Diabetes is a worldwide public health issue. By 2013, the number of patients with